Metraipolis › archive › dc_c30b2135cd45
4C-TFM — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/4C-TFM
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-11-06T17:05:50.806Z
- SHA-256 of the archived text
66d914f7f358d8c3657aa97f49b0f0520bf4eba3feeab32c86d038a3d1887c9c- Stable URL of this page
https://metraipolis.com/documento/dc_c30b2135cd45
How to cite
4C-TFM — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/4C-TFM (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_c30b2135cd45 (Metraipolis archive dc_c30b2135cd45, sha256 66d914f7f358d8c3657aa97f49b0f0520bf4eba3feeab32c86d038a3d1887c9c)
BibTeX
@misc{dcc30b2135cd45,
title = {4C-TFM — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/4C-TFM},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_c30b2135cd45; sha256 66d914f7f358d8c3657aa97f49b0f0520bf4eba3feeab32c86d038a3d1887c9c},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/4C-TFM. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
4C-TFM, also known as TFM-Ariadne or 4C-DOTFM, as well as 4-trifluoromethyl-2,5-dimethoxy-α-ethylphenethylamine, is a serotonin 5-HT2 receptor agonist of the phenethylamine, phenylisobutylamine, and 4C families related to Ariadne (4C-D). It is a close analogue of the psychedelic drugs 2C-TFM and DOTFM, with 2C-TFM having no substitution at the α carbon, DOTFM having an α-methyl group, and 4C-TFM having an α-ethyl group. The drug is a potent agonist of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors. It shows similar efficacy as an agonist of these receptors as Ariadne, but shows about 6.4-fold higher potency as a serotonin 5-HT2A receptor agonist in comparison. Like Ariadne, 4C-TFM produces an attenuated head-twitch response relative to the psychedelic drug DOPR, with a similar maximal response as Ariadne. The chemical synthesis of 4C-TFM has been described. 4C-TFM was first described in the scientific literature by Michael Cunningham and colleagues in 2023. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico). Fonte: Wikipedia in inglese, voce «4C-TFM» — https://en.wikipedia.org/wiki/4C-TFM Wikidata Q138008008: «pharmaceutical compound» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q138008008 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/4C-TFM?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1371210543, consultata il 2026-11-06T17:01:49.649Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 5e8c030408c1daac94237985266ae4627bfc59071cf046f585b69507aa96dd62